Summary and perspectives

Acta Oncologica

Volumn 35, Issue 3, 1996, Pages 385-390

  Britton, Keith E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RADIOISOTOPE; TUMOR MARKER; ANTIBODY CONJUGATE; ANTIIDIOTYPIC ANTIBODY; DIAGNOSTIC AGENT;

CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER RESEARCH; CONFERENCE PAPER; HUMAN; ISOTOPE LABELING; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RADIOIMMUNOTHERAPY; RADIOISOTOPE THERAPY; ANIMAL; ARTICLE; DISEASE MODEL; IMMUNOLOGY; INSTRUMENTATION; NEOPLASM; RADIATION DOSE; RADIOIMMUNOASSAY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOCONJUGATES; NEOPLASMS; RADIATION DOSAGE; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY DOSAGE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL;

EID: 0029704309     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609101656     Document Type: Conference Paper

References (21)

1. Rhodes BA, Zamora PA, Newell KD, Valdez EF. Tc-99m-labelling of murine monoclonal antibody fragments. J Nucl Med 1986; 27: 685-93.
2. Lanteiegne D, Hnatowich DJ. The labelling of DTPA coupled proteins with Tc-99m. Int J Appl Radiol Biol 1984; 35: 617-21.
3. Mather SJ, Ellison D. Reduction medicated Tc-99m labelling of monoclonal antibodies. J Nucl Med 1990; 31: 692-7.
4. Fritzberg AR, Abrams PG, Beaumier PL, et al. Specific and subtle labelling of antibodies with Technetium-99m with a diamide dithiolate chelating agent. Proc Natl Acad Sci USA 1988; 85: 4025-9.
5. Solanki K, Gill R, Stoker M. A case for automated radiopharmaceutical dispensing. Nucl Med Commun 1993; 14: 282.
6. Granowska M, Britton KE, Mather SJ, et al. Radioimmunoscintigraphy with Technetium-99m monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med 1993; 20: 483-9.
7. Lo Buglio AF, Wheeler RH, Trang J, et al. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response. Proc Natl Acad Sci USA 1989; 86: 4220-4.
8. 99mTechnetium-labelled antibodies for radioimmunoscintigraphy In: Epenetos AA, ed. Monoclonal antibodies 2. London: Chapman and Hall, 1993: 375-82.
9. Britton KE. Radiobiology workshop - an elemental dose approach to radioimmunotherapy. In: Epenetos AA. ed. Monoclonal antibodies 2. London: Chapman and Hall, 1993: 383-90.
10. Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1976; 8: 79-94.
11. Hird V, Maraveyas A, Snook D, et al. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer 1993; 68: 403-6.
12. Oehr P, Wagner V, Briele B, et al. Improved survival of patients with advanced ovarian cancer after repeated immunoscintigraphy and induction of anti idiotypic antibodies. J Nucl Med 1991; 32: 1051.
13. Britton KE, Mather SJ, Granowska M. Radiolabelled monoclonal antibodies in oncology III, radioimmunotherapy. Nucl Med Commun 1991; 12: 333-47.
14. Rao DV, Howell RW. Time dose fractionation in radioimmunotherapy: implication for selecting radionuclides. J Nucl Med 1993; 34: 1801-10.
15. Howell RW, Goddu SM, Rao DV. Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. J Nucl Med 1994; 35: 1861-9.
16. Foxwell BMJ, Band HA, Long J, et al. Conjunction of monoclonal antibodies to a synthetic peptide substitute for protein kinase: a method of labelling antibodies with 32-P. Br J Cancer 1988; 57: 489-503.
17. Britton KE, Band HA, Creighton AM, et al. Radioimmunotherapy, RIT, with 32-P labelled antibodies, a preliminary report. Eur J Nucl Med 1994; 21: 783.
18. 32P-labelled antibodies for radioimmunotherapy: a review of recent developments and preliminary report of the first phase I studies. Tumour Targeting 1995; 1: 1-8.
19. Rosler H, Noelpp U, Baluenstein P. Endoarterial radionuclide embolising tumour therapy In: Schubiger PA, Haslar PH, eds. Radionuclides for therapy. Proc 4th Bottstein Colloquium, Weirenlingen, Roche, Basle, 1986: 227-44.
20. Holliger P, Prosperio T, Winter G. 'Diabodies': small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 1993; 90: 6444-8.
21. Paganelli G, Magnani P, Zito F, et al. Three step monoclonal antibody tumour targetting in carcinoembryonic positive patients. Cancer Res 1991; 51: 5960-6.